Scinovex
article Open AccessTop 1% cited

COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China

Allergy · 2020 · Vol. 75(7) · pp. 1742–1752
Qingxian CaiDeliang HuangPengcheng OuHong YuZhibin ZhuXia ZhangYinan SuZhenghua MaYiming ZhangZhiwei LiQing HeLei LiuYang FuJun Chen

Abstract

In a designated hospital outside Hubei Province, COVID-2019 patients could be effectively managed by properly using the existing hospital system. Mortality may be lowered when cases are relatively mild, and there are sufficient medical resources to care and treat the disease.

Disaster Response and ManagementHealthcare Systems and ReformsPneumonia and Respiratory InfectionsCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakChinaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePandemicVirologyBetacoronavirusEnvironmental healthInfectious disease (medical specialty)

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 Drug TreatmentAdolescentAdultAge FactorsAntiviral AgentsBlood SedimentationC-Reactive ProteinChildChinaFemaleHospitalizationHumans

Funding

  • Bill and Melinda Gates Foundation
  • Sanming Project of Medicine in Shenzhen
Citations
498
FWCI
92.94
field-weighted impact
References
20
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.